12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersElutia (NASDAQ:ELUT) stock rose 24.2% to $4.31 during Tuesday's regular session. The market value of their outstanding shares is at $104.9 million. Trinity Biotech (NASDAQ:TRIB) stock rose 20.6
Elutia | 10-Q: Quarterly report
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
SILVER SPRING, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia"), a company pioneering drug-eluting biomatrix products, is excited to announce its participation in the upco
Earnings Call Summary | Elutia(ELUT.US) Q1 2024 Earnings Conference
The following is a summary of the Elutia, Inc. (ELUT) Q1 2024 Earnings Call Transcript:Financial Performance:Elutia reported Q1 revenue of $6.7 million, which represented substantial growth.The compan
Elutia Is Maintained at Overweight by Cantor Fitzgerald
Elutia Is Maintained at Overweight by Cantor Fitzgerald
Elutia Price Target Cut to $5.00/Share From $6.00 by Cantor Fitzgerald
Elutia Price Target Cut to $5.00/Share From $6.00 by Cantor Fitzgerald
Express News | Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $5
Elutia Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 70.65% Cantor Fitzgerald $6 → $5 Maintains Overweight 11/14/2023 104.78% Cantor Fitzgerald $8 →
Elutia Q1 2024 GAAP EPS $(0.75) Misses $(0.41) Estimate, Sales $6.694M Beat $6.100M Estimate
Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.41) by 82.93 percent. This is a 222.95 percent decrease over earnings of $0.61 pe
Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, Vs. Street Est of $6.1M
04:23 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M
Press Release: Elutia Announces First Quarter 2024 Results: SimpliDerm(R) Sales Increase 55%, CanGaroo(R)RM on Track for Second Quarter 2024 FDA Clearance
Elutia Announces First Quarter 2024 Results: SimpliDerm(R) Sales Increase 55%, CanGaroo(R)RM on Track for Second Quarter 2024 FDA Clearance SILVER SPRING, Md., May 09, 2024 (GLOBE NEWSWIRE) -- Elutia
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
SILVER SPRING, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia"), a company pioneering drug-eluting biomatrix products, today announced that it will release its first quart
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1
SILVER SPRING, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia"), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive
Q4 2023 Elutia Inc Earnings Call
Earnings Call Summary | Elutia(ELUT.US) Q4 2023 Earnings Conference
The following is a summary of the Elutia, Inc. (ELUT) Q4 2023 Earnings Call Transcript:Financial Performance:Elutia reported a slight increase in net sales in 2023, reaching $24.7 million, primarily d
Recap: Elutia Q4 Earnings
Elutia (NASDAQ:ELUT) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsElutia missed estimated earnings by -136.
Express News | Elutia Q4 2023 GAAP EPS $(0.660) Misses $(0.280) Estimate, Sales $5.875M Miss $6.550M Estimate
Earnings Flash (ELUT) ELUTIA Posts Q4 Revenue $5.9M, Vs. Street Est of $6.6M
04:18 PM EST, 03/07/2024 (MT Newswires) -- Earnings Flash (ELUT) ELUTIA Posts Q4 Revenue $5.9M, vs. Street Est of $6.6M
Press Release: Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM(R) Clearance Decision in First Half of 2024
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM(R) Clearance Decision in First Half of 2024 SILVER SPRING, Md., March 07, 2024 (GLOBE NEWSWIRE) -- Elutia In
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. • Stevanato Gr (NYSE:STVN) is likely to report quarte
No Data